Pyxis Oncology, Inc. (PYXS) stock
PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.44+0.03 (+2.13%)
Close on Nov 17, 2026Market cap $120.11MP/E –Yield –
Pyxis Oncology total assets
Total assets on the balance sheet at the end of each period.
Pyxis Oncology's total assets was $54.92M at Jun 30, 2026. For fiscal 2025 it was $91.52M, down 41.8% from the year before. The highest annual figure on record is $280.02M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $91.52M | -41.8% |
| FY2024 | Dec 31, 2024 | $157.18M | -9.5% |
| FY2023 | Dec 31, 2023 | $173.73M | -17.8% |
| FY2022 | Dec 31, 2022 | $211.38M | -24.5% |
| FY2021 | Dec 31, 2021 | $280.02M | +2658.6% |
| FY2020 | Dec 31, 2020 | $10.15M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $54.92M | -55.4% |
| Q1 FY2026 | Mar 31, 2026 | $64.30M | -52.7% |
| Q4 FY2025 | Dec 31, 2025 | $91.52M | -41.8% |
| Q3 FY2025 | Sep 30, 2025 | $105.60M | -45.9% |
| Q2 FY2025 | Jun 30, 2025 | $123.22M | -40.9% |
| Q1 FY2025 | Mar 31, 2025 | $135.87M | -38.3% |
| Q4 FY2024 | Dec 31, 2024 | $157.18M | -9.5% |
| Q3 FY2024 | Sep 30, 2024 | $195.31M | +4.6% |
| Q2 FY2024 | Jun 30, 2024 | $208.39M | +18.9% |
| Q1 FY2024 | Mar 31, 2024 | $220.22M | +20.5% |
| Q4 FY2023 | Dec 31, 2023 | $173.73M | -17.8% |
| Q3 FY2023 | Sep 30, 2023 | $186.69M | -16.6% |
| Q2 FY2023 | Jun 30, 2023 | $175.23M | -27.8% |
| Q1 FY2023 | Mar 31, 2023 | $182.80M | -27.7% |
| Q4 FY2022 | Dec 31, 2022 | $211.38M | -24.5% |
| Q3 FY2022 | Sep 30, 2022 | $223.90M | +60.5% |
| Q2 FY2022 | Jun 30, 2022 | $242.56M | +2289.5% |
| Q1 FY2022 | Mar 31, 2022 | $252.70M | – |
| Q4 FY2021 | Dec 31, 2021 | $280.02M | – |
| Q3 FY2021 | Sep 30, 2021 | $139.49M | – |
| Q4 FY2020 | Dec 31, 2020 | $10.15M | – |
See a number that looks wrong?